2020 Q4 Infinity Pharmaceuticals Reports Full Year 2020 Financial Results and Provides Update on Eganelisib Development Form 10-K Q3 Infinity Pharmaceuticals Provides Company Update and Third Quarter 2020 Financial Results Form 10-Q Q2 Infinity Pharmaceuticals Provides Company Update and Second Quarter 2020 Financial Results Form 10-Q Q1 Infinity Pharmaceuticals Provides Company Update and First Quarter 2020 Financial Results Form 10-Q 2019 Q4 Infinity Pharmaceuticals Reports Full Year 2019 Financial Results and Provides Company Update Form 10-K Q3 Infinity Pharmaceuticals Provides Company Update and Third Quarter 2019 Financial Results Form 10-Q Q2 Infinity Pharmaceuticals Provides Company Update and Second Quarter 2019 Financial Results Form 10-Q Q1 Infinity Pharmaceuticals Provides Company Update and First Quarter 2019 Financial Results Form 10-Q 2018 Q4 Infinity Pharmaceuticals Reports Full Year 2018 Financial Results and Provides Company Update Form 10-K Q3 Infinity Pharmaceuticals Provides Company Update and Third Quarter 2018 Financial Results Form 10-Q Q2 Infinity Pharmaceuticals Provides Company Update and Second Quarter 2018 Financial Results Form 10-Q Q1 Infinity Pharmaceuticals Provides Company Update and First Quarter 2018 Financial Results Form 10-Q 2017 Q4 Infinity Pharmaceuticals Provides Company Update and Reports Fourth Quarter and Full Year 2017 Financial Results Form 10-K Q3 Infinity Provides Company Update and Reports Third Quarter 2017 Financial Results Form 10-Q Q2 Infinity Provides Company Update and Reports Second Quarter 2017 Financial Results Form 10-Q Q1 Infinity Provides Company Update and Reports First Quarter 2017 Financial Results Form 10-Q 2016 Q4 Infinity Provides Company Update and Reports Fourth Quarter 2016 Financial Results Form 10-K Q3 Infinity Provides Company Update and Reports Third Quarter 2016 Financial Results Form 10-Q Q2 Infinity Provides Company Update And Reports Second Quarter 2016 Financial Results Form 10-Q
2020 Q4 Infinity Pharmaceuticals Reports Full Year 2020 Financial Results and Provides Update on Eganelisib Development Form 10-K Q3 Infinity Pharmaceuticals Provides Company Update and Third Quarter 2020 Financial Results Form 10-Q Q2 Infinity Pharmaceuticals Provides Company Update and Second Quarter 2020 Financial Results Form 10-Q Q1 Infinity Pharmaceuticals Provides Company Update and First Quarter 2020 Financial Results Form 10-Q 2019 Q4 Infinity Pharmaceuticals Reports Full Year 2019 Financial Results and Provides Company Update Form 10-K Q3 Infinity Pharmaceuticals Provides Company Update and Third Quarter 2019 Financial Results Form 10-Q Q2 Infinity Pharmaceuticals Provides Company Update and Second Quarter 2019 Financial Results Form 10-Q Q1 Infinity Pharmaceuticals Provides Company Update and First Quarter 2019 Financial Results Form 10-Q 2018 Q4 Infinity Pharmaceuticals Reports Full Year 2018 Financial Results and Provides Company Update Form 10-K Q3 Infinity Pharmaceuticals Provides Company Update and Third Quarter 2018 Financial Results Form 10-Q Q2 Infinity Pharmaceuticals Provides Company Update and Second Quarter 2018 Financial Results Form 10-Q Q1 Infinity Pharmaceuticals Provides Company Update and First Quarter 2018 Financial Results Form 10-Q 2017 Q4 Infinity Pharmaceuticals Provides Company Update and Reports Fourth Quarter and Full Year 2017 Financial Results Form 10-K Q3 Infinity Provides Company Update and Reports Third Quarter 2017 Financial Results Form 10-Q Q2 Infinity Provides Company Update and Reports Second Quarter 2017 Financial Results Form 10-Q Q1 Infinity Provides Company Update and Reports First Quarter 2017 Financial Results Form 10-Q 2016 Q4 Infinity Provides Company Update and Reports Fourth Quarter 2016 Financial Results Form 10-K Q3 Infinity Provides Company Update and Reports Third Quarter 2016 Financial Results Form 10-Q Q2 Infinity Provides Company Update And Reports Second Quarter 2016 Financial Results Form 10-Q
